Variant report
Variant | esv3333426 |
---|---|
Chromosome Location | chr13:70035651-70037749 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74090581 | chr13:70035674-70035675 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs556055944 | chr13:70035676-70035677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17609565 | chr13:70035690-70035691 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs537981336 | chr13:70035742-70035743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553738526 | chr13:70035781-70035782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9317819 | chr13:70035782-70035783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs141344604 | chr13:70035809-70035810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540213244 | chr13:70035825-70035826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192751524 | chr13:70035886-70035887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148550334 | chr13:70035899-70035900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372878105 | chr13:70035900-70035901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577434509 | chr13:70035906-70035907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546402009 | chr13:70035934-70035935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563105160 | chr13:70035970-70035971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17609640 | chr13:70035994-70035995 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs541987195 | chr13:70036065-70036066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561764220 | chr13:70036066-70036067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17085123 | chr13:70036080-70036081 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs543483380 | chr13:70036087-70036088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74090582 | chr13:70036181-70036182 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570745955 | chr13:70036186-70036187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533102835 | chr13:70036187-70036188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550031850 | chr13:70036197-70036198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529226578 | chr13:70036202-70036203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569553537 | chr13:70036211-70036212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535266121 | chr13:70036218-70036219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548113618 | chr13:70036224-70036225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554644064 | chr13:70036231-70036232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532496792 | chr13:70036242-70036243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs59670522 | chr13:70036245-70036246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144125165 | chr13:70036246-70036247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184747012 | chr13:70036252-70036253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534217155 | chr13:70036254-70036255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553855064 | chr13:70036258-70036259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551980637 | chr13:70036333-70036334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529916059 | chr13:70036445-70036446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577148650 | chr13:70036455-70036456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187716112 | chr13:70036478-70036479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371750879 | chr13:70036495-70036496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs111409401 | chr13:70036516-70036517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187119 | chr13:70036544-70036545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576758008 | chr13:70036649-70036650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2782447 | chr13:70036687-70036688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142497245 | chr13:70036690-70036691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79367573 | chr13:70036716-70036717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77222768 | chr13:70036720-70036721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542395443 | chr13:70036777-70036778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76816928 | chr13:70036778-70036779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150625206 | chr13:70036802-70036803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138681311 | chr13:70036861-70036862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:70031600-70037000 | Enhancers | Brain Germinal Matrix | brain |
2 | chr13:70032800-70036200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr13:70033000-70036400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:70035200-70036000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr13:70035200-70036200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr13:70035200-70036200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr13:70035400-70035800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr13:70035400-70035800 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr13:70035400-70035800 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr13:70035400-70035800 | Enhancers | Fetal Brain Male | brain |
11 | chr13:70035400-70035800 | Enhancers | Fetal Brain Female | brain |
12 | chr13:70035400-70035800 | Enhancers | Fetal Lung | lung |
13 | chr13:70035400-70036000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr13:70035400-70036000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr13:70035400-70036000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
16 | chr13:70035400-70036400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr13:70036400-70036800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
18 | chr13:70036400-70037000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
19 | chr13:70036800-70037200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr13:70037000-70037200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |